vanadates has been researched along with afimoxifene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freiss, G; Vignon, F | 1 |
| Jebe, E; Petrunkina, AM; Töpfer-Petersen, E | 1 |
| Band, H; Cook, SJ; Wiggins, CM | 1 |
3 other study(ies) available for vanadates and afimoxifene
| Article | Year |
|---|---|
Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells.
Topics: Amino Acid Sequence; Binding Sites; Breast Neoplasms; Cell Division; Chromatography, High Pressure Liquid; Epidermal Growth Factor; ErbB Receptors; Estrogen Antagonists; Homeostasis; Humans; Kinetics; Molecular Sequence Data; Phosphorylation; Protein Tyrosine Phosphatases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Vanadates | 1994 |
Regulatory and necrotic volume increase in boar spermatozoa.
Topics: Animals; Annexin A5; Cell Size; Chloride Channels; Enzyme Inhibitors; Hypertonic Solutions; Male; Necrosis; Phenols; Phosphoprotein Phosphatases; Phosphorylation; Protein-Tyrosine Kinases; Quinidine; Semen Preservation; Spermatozoa; Staining and Labeling; Staurosporine; Swine; Tamoxifen; Tyrosine; Vanadates | 2005 |
c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
Topics: Animals; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cell Line; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; Fibroblasts; Humans; Membrane Proteins; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Proteasome Endopeptidase Complex; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Serine; Tamoxifen; Tyrosine; Ubiquitin; Vanadates | 2007 |